This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, December 15, 2008
Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%
Dec 12, 2008 - Akorn, Inc. today announced that the U.S. Food and Drug Administration has granted approval for Akorn's Abbreviated New Drug Application for Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%.
No comments:
Post a Comment